In Brief: Biosite Diagnostics
This article was originally published in The Gray Sheet
Biosite Diagnostics: Triage point-of-care panel for CK-MB, myoglobin and troponin I measurement gains 510(k) clearance to be used in conjunction with the Triage meter for myocardial infarction detection. Biosite awaits pending 510(k) clearances for test quality control/calibration and Triage meter products before launching the Triage panel. The 15-minute test consists of a small, single-use cartridge utilizing capillary technology to control blood flow through zones containing immobilized antibodies to the three biochemical markers, which are quantitatively measured by the Triage Meter. Data from a four-center, 800-patient study show "sensitivity and specificity of the Triage cardiac panel was substantially equivalent to commercially available analyzer-based assays," the firm claims...
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.